| abstract |
This invention is directed to methods for preventing or ameliorating sleep-related breathing disorders. The method comprises administration to a patient in need thereof an effective dose of one or more calcitonin gene-related peptide (CGRP) receptor antagonists or release inhibitors. The CGRP receptor antagonist or combination of CGRP receptor antagonists can be administered in conjunction with one or more serotonin receptor agonists, one or more cannabinoid receptor agonists, one or more serotonin reuptake inhibitors, a combination of reuptake inhibitors, other agents, or any combination of the foregoing. |